Inventor

Shigeharu Fukuda

Inventor

Okayama, JP

Overview

1994–2020

Patent span

Human necessities

Primary field (CPC A)

Patents· 64 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes16%

C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture10%

A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for9%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations9%

A61QSpecific use of cosmetics or similar toiletry preparations9%

C07HSugars8%

C12NMicroorganisms or enzymes7%

C12YEnzymes4%

A21DTreatment of flour or dough for baking, e.g. by addition of materials4%

A23CDairy products, e.g. milk, butter or cheese4%

PatentTitleYear

10,603,333Process for producing a particulate composition comprising an hydrous crystalline 2-o-alpha-d-glucosyl-ascorbic acid2020 10,076,130Branched alpha-glucan, alpha-glucosyltransferase which forms the glucan, their preparation and uses2018 10,071,042External dermatological agent for anti-ageing2018 9,872,872Process for producing a particulate composition comprising an hydrous crystalline 2-O-a-D-glucosyl-L-ascorbic acid2018 9,757,408'Therapeutic agent for inflammatory diseases, containing adenosine N1-oxide as an effective ingredient'2017 9,528,134'Branched Î±-glucan, Î±-glucosyltransferase which forms the glucan, their preparation and uses'2016 9,492,368'External preparation for skin'2016 9,301,968'Therapeutic agent for inflammatory diseases, containing adenosine N1-oxide as an effective ingredient'2016 9,265,781'Process for producing a particulate composition comprising anhydrous crystalline 2-O-alpha-D-glucosyl-L-ascorbic acid'2016 9,215,887'Method for inhibiting coloring of a syrupy sweetener comprising a non-reducing oligosaccharide having a beta-fructofranosidic linkage and a reducing saccharide, and use thereof'2015 9,206,215'Hydrous crystalline 2-O-Î±-D-glucosyl-L-ascorbic acid, particulate composition comprising the same, their preparation and uses'2015 9,186,368'Process for producing a particulate composition comprising an hydrous crystalline 2-O-Î±-D-glucosyl-L-ascorbic acid'2015 9,175,282'Cellobiose 2-epimerase, its preparation and uses'2015 9,090,923'Branched alpha-glucan, alpha-glucosyltransferase which forms the glucan, their preparation and uses'2015 9,066,968'Fluid for peritoneal dialysis'2015 8,940,715'Lipid-regulating agent and use thereof'2015 8,765,416'Particulate composition containing anhydrous crystalline 2-O-alpha-D-glucosyl-L-ascorbic acid, process for producing the same, and uses thereof'2014 8,759,030'Process for producing 2-O-alpha-D-glucopyranosyl-L-ascorbic acid'2014 8,673,608'Branched Î±-glucan, Î±-glucosyltransferase which forms the glucan, their preparation and uses'2014 8,642,575'Method of inhibiting formation of volatile aldehydes and/or decomposition of fatty acids and use thereof'2014 8,633,005'Isocyclomaltooligosaccharide(s), isocyclomaltooligosaccharide-forming enzyme, their preparation and uses'2014 8,524,889'Highly-branched starch, its production and uses'2013 8,357,782'Monoclonal antibodies specific for human interferon-alpha subtype alpha 8'2013 8,324,375'Branched Î±-glucan, Î±-glucosyltransferase which forms the glucan, their preparation and uses'2012 8,168,778'Highly-branched starch, its production and uses'2012 7,994,155'Accelerator for mineral absorption and use thereof'2011 7,973,021'Immunomodulating agent in gut'2011 7,951,530'Cyclic maltosylmaltose, cyclic maltosymaltose-forming enzyme, their preparation and uses'2011 7,854,922'Skin preparation for external use characterized by containing sugar derivative of Î±, Î±-trehalose'2010 7,811,797'Î±-isomaltosylglucosaccharide-forming enzyme, process and uses of the same'2010 7,799,765'Association compound of trehalose or maltitol with metal ion compound'2010 7,790,214'Method of inhibiting 2,3-butanedione formation from processed cacao bean product'2010 7,732,426'Isocyclomaltooligosaccharide (S) , isocyclomaltooligosaccharide-forming enzyme, their preparation and uses'2010 7,718,404'Î±-isomaltosylglucosaccharide-forming enzyme, process and uses of the same'2010 7,709,230'Process for producing isomaltose and uses thereof'2010 7,592,160'Processes for producing isomaltose and isomaltitol and use thereof'2009 7,582,463'Non-reducing saccharide-forming enzyme, trehalose-releasing enzyme, and process for producing saccharides using the enzymes'2009 7,575,900'Non-reducing saccharide-forming enzyme, trehalose-releasing enzyme, and process for producing saccharides using the enzymes'2009 7,375,095'Sugar derivative'2008 7,355,014'Interferon-Î³ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use'2008 7,309,697'Cyclic maltosylmatose'2007 7,241,606'Î±-Isomaltosylglucosaccharide synthase, process for producing the same and use thereof'2007 7,214,667'Drugs against articular failure'2007 7,211,422'Polypeptide having Î±-isomaltosylglucosaccharide synthase activity'2007 7,192,746'Î±-Isomaltosyltransferase, process for producing the same and use thereof'2007 7,186,535'Non-reducing saccharide-forming enzyme, trehalose-releasing enzyme, and process for producing saccharides using the enzymes'2007 7,186,824'Reduction inhibitory agent for active-oxygen eliminating activity'2007 7,186,701'Dehydrating agent and method for dehydrating moist article using the agent and dehydrated article obtained by the method'2007 7,163,711'Crystalline Î±-D-glucosyl Î±-D-galactoside, saccharide composition comprising the same, process for producing the same, and uses thereof'2007 7,135,458'Interferon-Î³ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use'2006 7,098,013'Polypeptide having Î±-isomaltosyl-transferase activity'2006 6,524,625'Physiologically active extract obtained from indigo plant polygonum tinctorium'2003 6,497,862'Composition for inhibiting body odor and uses thereof'2002 6,294,360'Saccharide composition containing trehalulose, its preparation and uses'2001 6,232,294'Neuro-function regulatory agent'2001 6,224,872'Composition'2001 6,207,641'Pharmaceutical composition containing IFN-.gamma. inducing polypeptide or factor for treating and/or preventing IFN-.gamma. susceptive diseases'2001 6,200,783'Process for producing trehalose and sugar alcohols'2001 6,153,228'Propolis extract'2000 6,153,227'Propolis extract'2000 5,981,498'Agent for improving the blood circulation'1999 5,863,771'Saccharide composition comprising maltooligosylturanose and maltooligosylpalatinose, its preparation and uses'1999 5,824,521'Saccharide composition containing trehalulose, its preparation and uses'1998 5,331,091'Melanin formation-inhibitory protein, and its preparation and uses'1994

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1994–2014Patents assigned to HAYASHIBARA BIOCHEM LAB (39)· patent assignee history

1994–2020Based in Okayama, JP· patent location history

2002–2020Patents assigned to HAYASHIBARA CO (23)· patent assignee history

2012–2016Patents assigned to FUKUDA SHIGEHARU (14)· patent assignee history

2012–2016Patents assigned to MIYAKE TOSHIO (9)· patent assignee history

2012–2016Patents assigned to NISHIMOTO TOMOYUKI (7)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
HAYASHIBARA BIOCHEM LAB	39	1994–2014
HAYASHIBARA CO	23	2002–2020
FUKUDA SHIGEHARUself	14	2012–2016
MIYAKE TOSHIO	9	2012–2016
NISHIMOTO TOMOYUKI	7	2012–2016

Locations

Location	Patents	Span
Okayama, JP	64	1994–2020